What Is Addyi? The Controversy Behind the Drug Nicknamed the ‘Female Viagra’
Marketed as a breakthrough for low libido in women, flibanserin’s approval followed two FDA rejections, a controversial campaign, and safety concerns
Jun 6, 2025Marketed as a breakthrough for low libido in women, flibanserin’s approval followed two FDA rejections, a controversial campaign, and safety concerns
Jun 6, 2025Help fund our fight for improved medication safety and transparency by supporting our independent journalism.
Give NowIndependent, science-based journalism delivered directly to your inbox.
Learn about your medications and treatment options straight from independent experts.
WATCH